Not applicableStudy completedNCT04728113What this trial is testingEarly Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)Who this might be right forUveal Melanoma Institut Curie 162
Large-scale testing (Phase 3)Looking for participantsNCT07804186What this trial is testingStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal MelanomaWho this might be right forUveal Melanoma IDEAYA Biosciences 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT06784648What this trial is testingDifferent Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic MelanomaWho this might be right forMelanoma MetastaticMelanoma of SkinMelanoma BRAF V600E/K Mutated+7 more BioInvent International AB 35
Early research (Phase 1)Looking for participantsNCT06805825What this trial is testingThe c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitWho this might be right forGastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more Novelty Nobility, Inc. 67
Early research (Phase 1)Not Yet RecruitingNCT07183852What this trial is testingLocoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic MelanomaWho this might be right forMetastatic Uveal MelanomaMetastatic Cutaneous Melanoma Vastra Gotaland Region 18
Testing effectiveness (Phase 2)Study completedNCT00450255What this trial is testingVEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Active Not RecruitingNCT05987332What this trial is testingIDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaWho this might be right forMetastatic Uveal Melanoma IDEAYA Biosciences 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717126What this trial is testingA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal MelanomaWho this might be right forUveal MelanomaOcular Melanoma iOnctura 85
Very early researchEnded earlyNCT01730157What this trial is testingRadioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+5 more Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT03947385What this trial is testingStudy of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsWho this might be right forMetastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1 more IDEAYA Biosciences 336
Testing effectiveness (Phase 2)Study completedNCT00738361What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryWho this might be right forIntraocular Melanoma Ohio State University Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868What this trial is testingAPG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsWho this might be right forUnresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more Ascentage Pharma Group Inc. 230
Testing effectiveness (Phase 2)Looking for participantsNCT06413680What this trial is testingA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyWho this might be right forMelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Ended earlyNCT05308901What this trial is testingLenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal MelanomaWho this might be right forMelanoma, Uveal Providence Health & Services 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT01587352What this trial is testingVorinostat in Treating Patients With Metastatic Melanoma of the EyeWho this might be right forMetastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7 National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT04551352What this trial is testingRO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive MelanomasWho this might be right forCutaneous MelanomaUveal MelanomaMucosal Melanoma Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07803562What this trial is testingLow Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With TebentafuspWho this might be right forUveal Melanoma, Metastatic University of California, San Diego 34
Early research (Phase 1)Active Not RecruitingNCT04328844What this trial is testingAssess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersWho this might be right forSolid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more iOnctura 210
Testing effectiveness (Phase 2)Ended earlyNCT04589832What this trial is testingStudy of PAC-1 and Entrectinib for Patients With Metastatic Uveal MelanomaWho this might be right forUveal Melanoma Arkadiusz Z. Dudek, MD 6
Not applicableActive Not RecruitingNCT05812027What this trial is testingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more TScan Therapeutics, Inc. 1,150